Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4063 in adults with PLN R14del dilated cardiomyopathy
NL-OMON59476Phase 1Recruiting
- Sponsor
- AstraZeneca
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of AZD4063 in dilated cardiomyopathy (DCM), sponsored by AstraZeneca. Started Nov 2025; status: recruiting.
02
Drugs
AZD4063
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NL-OMON59476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59476.